세계의 말 건강관리 시장 규모, 점유율, 동향 분석 리포트 : 제품별(의약품, 백신), 적응증별, 활동별, 유통 채널별, 지역별, 부문별 예측(2022-2030년)
Equine Healthcare Market Size, Share & Trends Analysis Report By Product (Pharmaceuticals, Vaccines), By Indication, By Activity, By Distribution Channel, By Region, And Segment Forecasts, 2022 - 2030
Grand View Research, Inc.의 새로운 보고서에 따르면 세계의 말 건강관리 시장 규모는 2030년까지 43억 7,000만 달러에 이를 것으로 예측됩니다. 이 시장은 2022년부터 2030년까지 연평균 복합 성장률(CAGR) 6.1%로 확대될 것으로 예측됩니다.
목차
제1장 조사 방법과 범위
- 시장 세분화와 범위
- 조사 방법
- 정보 조달
- 구입한 데이터베이스
- GVR 내부 데이터베이스
- 2차 정보
- 1차 조사
- 1차 조사 상세
- 정보 또는 데이터 분석
- 시장 형성 및 검증
- 모델 상세
- 2차 정보 리스트
제2장 개요
제3장 말 건강관리 시장 변수 동향과 범위
- 시장 계열 전망
- 적응증별 침투 및 성장 전망 매핑, 2021년
- 시장 역학
- 시장 성장 촉진요인 분석
- 시장 성장 억제요인 분석
- Porter's Five Forces 분석
- Porter's Five Forces 분석
- 공급 기업의 교섭력
- 바이어의 교섭력
- 대체품의 위협
- 신규 진출업체의 위협
- 경쟁 기업간 경쟁 관계
- PESTLE 분석
- 정치적/법적 상황
- 경제 정세
- 사회 정세
- 기술 정세
- 추정 마두수, 2017-2021년, 주요 국가별
- 규제 프레임워크와 상환 상황
- 가격 분석
- 주요 지역별 추정 질환 유병률 분석
- 말 건강관리 : COVID-19의 영향
- 현재 및 향후 영향 분석
- COVID-19가 시장 관계자에게 미치는 영향
제4장 말 건강관리 시장 : 부문 분석, 제품별, 2017-2030년(백만 달러)
- 제품 시장 점유율 분석, 2021년 및 2030년
- 말 건강관리 시장 : 제품 변동 분석
- 백신
- 의약품
- 약용 사료첨가물
- 진단
- 소프트웨어 및 서비스
- 기타
제5장 말 건강관리 시장 : 부문 분석, 적응증별, 2017-2030년(백만 달러)
- 적응증 시장 점유율 분석, 2021년 및 2030년
- 말 건강관리 시장 : 적응증 변동 분석
- 근골격계 질환
- 기생충 대책
- 내과
- 말 헤르페스 바이러스
- 말 뇌척수염
- 말 인플루엔자
- 웨스트 나일 바이러스
- 파상풍
- 기타
제6장 말 건강관리 시장 : 부문 분석, 활동별, 2017-2030년(백만 달러)
- 활동 시장 점유율 분석, 2021년 및 2030년
- 말 건강관리 시장 : 활동 변동 분석
- 스포츠/레이스
- 레크리에이션
- 기타
제7장 말 건강관리 시장 : 부문 분석, 유통 채널별, 2017-2030년(100만 달러)
- 유통 채널 시장 점유율 분석, 2021년 및 2030년
- 말 건강관리 시장 : 유통 채널 분석 변동 분석
- 동물병원 및 진료소
- E-Commerce
- 기타
제8장 말 건강관리 시장 : 지역 시장 분석, 제품별, 적응증, 활동 및 유통 채널 2017-2030년(백만 달러)
- 지역별 시장 점유율 분석, 2021년 및 2030년
- 지역별 시장 현황
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카(MEA)
제9장 말 건강관리 시장 - 경쟁 구도 환경
- 기업 개요
- Zoetis
- 기업 개요
- 재무 실적
- 제품/서비스 벤치마킹
- 전략적 이니셔티브
- Boehringer Ingelheim International GmbH
- 기업 개요
- 재무 실적
- 제품/서비스 벤치마킹
- 전략적 이니셔티브
- Ceva
- 기업 개요
- 재무 실적
- 제품/서비스 벤치마킹
- 전략적 이니셔티브
- SOUND
- 기업 개요
- 재무 실적
- 제품/서비스 벤치마킹
- 전략적 이니셔티브
- MERCK & CO., INC.
- 기업 개요
- 재무 실적
- 제품/서비스 벤치마킹
- 전략적 이니셔티브
- Hallmarq Veterinary Imaging
- 기업 개요
- 재무 실적
- 제품/서비스 벤치마킹
- 전략적 이니셔티브
- ESAOTE SPA
- 기업 개요
- 재무 실적
- 제품/서비스 벤치마킹
- 전략적 이니셔티브
- Vetoquinol S.A.
- 기업 개요
- 재무 실적
- 제품/서비스 벤치마킹
- 전략적 이니셔티브
- IDEXX Laboratories, Inc.
- 기업 개요
- 재무 실적
- 제품/서비스 벤치마킹
- 전략적 이니셔티브
- Dechra Pharmaceuticals PLC
- 기업 개요
- 재무 실적
- 제품/서비스 벤치마킹
- 전략적 이니셔티브
- 시장 진출기업 분류
- 기업 시장 현황 분석 - 히트맵 분석
- 시너지효과 분석 : 주요 거래와 전략적 제휴
- 주요 기업 리스트
LSH 22.11.17
Equine Healthcare Market Growth & Trends:
The global equine healthcare market size is anticipated to reach USD 4.37 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.1% from 2022 to 2030. Increasing product R&D, demand for equine diagnostics, investments by key industry stakeholders, and the rising prevalence of diseases in horses are some of the major factors contributing to the market growth. For instance, in September 2021, the U.S. Department of Agriculture invested around USD 3.0 billion in the animal nutrition and health sector.
The Covid-19 pandemic had a notable impact, particularly on the horse racing/ sports sector. It led to reduced access to equine care services and the cancelation of equine shows. Teaching, training, competitions, events, tourism-related activities, and recreational activities were all discontinued as a result of COVID-19. Horse racing was adversely impacted across the world, along with the demand for horse boarding. Only Sweden continued to hold races within the EU. According to a survey conducted by Hippolia, French Equine Industry Cluster, 68.8% of respondents believed the recovery of the shortfall is impossible, and all equine competitions have been discontinued. A total of USD 385.89 million in sport horse losses were incurred as per estimates. However, the market recovered in 2021 owing to easing lockdown measures and improved access to equine healthcare.
Growing technological advancement, R&D, and initiatives by market players in equine diagnostics are key factors driving the market. For instance, according to a July 2022 article published by the American Veterinary Medical Association, a study was carried out to assess the diagnostic performance of a unique helical fan beam-based CT utilized for imaging horses with clinical head and neck complications. A total of over 120 horses were involved, and the medical records of those who had undergone head or neck CT scans at two university hospitals were examined. Age, sex, breed, the primary complaint, the amount of sedation utilized, the length of the operation, the use of any further diagnostic imaging techniques, the imaging diagnosis, the clinical diagnosis, and any imaging-related problems were all noted. The CT system proved to have short scanning times and reliable utility for regular imaging of horses' teeth and sinuses.
Furthermore, the rising prevalence of diseases in horses is another factor propelling the market growth. West Nile Virus, for instance, was positively identified in a 10-year-old unvaccinated Quarter Horse stallion in Nevada County who was exhibiting transient fever and neurological symptoms by the California Department of Food and Agriculture in September 2022. This was the 8th confirmed case of the equine WNV in California in 2022. Other positive cases were identified in six counties: three in Kern, one in Nevada, one in Sacramento, one in San Luis Obispo, one in Tehama, and three in Tulare. This is expected to promote awareness regarding equine diseases while fueling demand for timely vaccination of horses.
Equine Healthcare Market Report Highlights:
- Based on product, the pharmaceuticals segment dominated the market with a share of over 30.0% in 2021 owing to a high uptake and wide availability of these products
- The others product segment comprising regenerative medicine and stem cell therapy solutions is projected to be the fastest growing segment in the forecast period
- Based on indication, parasite control held the largest share of over 20.0% in 2021. It is due to the growing demand for effective parasiticides for the control of internal and external parasites
- The sports/racing activity segment dominated the market with a revenue share of over 40.0% in 2021 and is anticipated to grow at the fastest rate during the forecast period
- Based on distribution channel, veterinary hospitals and clinics held the largest share in 2021. The e-commerce segment is projected to expand at the fastest CAGR during the forecast period
- North America and Europe held notable shares in 2021. The Asia Pacific is expected to witness lucrative growth in the forecast period owing to a budding equine racing/ sports sector
Table of Contents
Chapter 1 Research Methodology & Scope
- 1.1 Market Segmentation & Scope
- 1.1.1 Estimates & Forecast Timeline
- 1.2 Research Methodology
- 1.3 Information Procurement
- 1.3.1 Purchased Database
- 1.3.2 Gvr's Internal Database
- 1.3.3 Secondary Sources
- 1.3.4 Primary Research
- 1.3.5 Details Of Primary Research
- 1.4 Information Or Data Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.7 List of Secondary Sources
Chapter 2 Executive Summary
- 2.1 Market Outlook
- 2.2 Segment Outlook
Chapter 3 Equine Healthcare Market Variables Trends & Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Parent Market Outlook
- 3.1.2 Ancillary Market Outlook
- 3.2 Penetration & Growth Prospect Mapping by Indication, 2021
- 3.3 Market Dynamics
- 3.3.1 Market Driver Analysis
- 3.3.2 Market Restraint Analysis
- 3.4 Industry Analysis - Porter's
- 3.4.1 Porter's Analysis
- 3.4.1.1 Bargaining Power Of Suppliers
- 3.4.1.2 Bargaining Power Of Buyers
- 3.4.1.3 Threat Of Substitutes
- 3.4.1.4 Threat Of New Entrants
- 3.4.1.5 Competitive Rivalry
- 3.4.2 Pestle Analysis
- 3.4.2.1 Political/Legal Landscape
- 3.5.2.2 Economic Landscape
- 3.5.2.3 Social Landscape
- 3.5.2.4 Technology Landscape
- 3.5 Estimated Equine Population, 2017 to 2021, by key countries
- 3.6 Regulatory Framework & Reimbursement Landscape
- 3.7 Pricing Analysis
- 3.8 Estimated Disease Prevalence Analysis, By Key Regions
- 3.9 Equine Healthcare: Covid-19 Impact
- 3.9.1 Current And Future Impact Analysis
- 3.9.2 Impact Of Covid-19 On Market Players
Chapter 4 Equine Healthcare Market: Segment Analysis, By Product, 2017 - 2030 (USD Million)
- 4.1 Product Market Share Analysis, 2021 & 2030
- 4.2 Equine Healthcare market: Product movement analysis
- 4.3 Vaccines
- 4.3.1 Vaccines Market Estimates And Forecasts, 2017 - 2030 (USD Million)
- 4.4 Pharmaceuticals
- 4.4.1 Pharmaceuticals Market Estimates And Forecasts, 2017 - 2030 (USD Million)
- 4.4.2 Parasiticides
- 4.4.2.1 Parasiticides Market Estimates And Forecasts, 2017 - 2030 (USD Million)
- 4.4.3 Anti-Infectives
- 4.4.3.1 Anti-Infectives Market Estimates And Forecasts, 2017 - 2030 (USD Million)
- 4.4.4 Anti-Inflammatory & Analgesics
- 4.4.4.1 Anti-Inflammatory & Analgesics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
- 4.4.5 Others
- 4.4.5.1 Other Pharmaceuticals Market Estimates And Forecasts, 2017 - 2030 (USD Million)
- 4.5 Medicinal Feed Additives
- 4.5.1 Medicinal Feed Additives Market Estimates And Forecasts, 2017 - 2030 (USD Million)
- 4.6 Diagnostics
- 4.6.1 Diagnostics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
- 4.7 Software & Services
- 4.7.1software & Services Market Estimates And Forecasts, 2017 - 2030 (USD Million)
- 4.8 Others
- 4.8.1. Others Market Estimates And Forecasts, 2017 - 2030 (USD Million)
Chapter 5 Equine Healthcare Market: Segment Analysis, By Indication, 2017 - 2030 (USD Million)
- 5.1 Indication Market Share Analysis, 2021 & 2030
- 5.2 Equine Healthcare market: Indication movement analysis
- 5.3 Musculoskeletal Disorders
- 5.3.1 Musculoskeletal Disorders Market Estimates And Forecasts, 2017 - 2030 (USD Million)
- 5.4 Parasite Control
- 5.4.1 Parasite Control Market Estimates And Forecasts, 2017 - 2030 (USD Million)
- 5.5 Internal Medicine
- 5.5.1 Internal Medicine Market Estimates And Forecasts, 2017 - 2030 (USD Million)
- 5.6 Equine Herpes Virus
- 5.6.1 Equine Herpes Virus Market Estimates And Forecasts, 2017 - 2030 (USD Million)
- 5.7 Equine Encephalomyelitis
- 5.7.1 Equine Encephalomyelitis Market Estimates And Forecasts, 2017 - 2030 (USD Million)
- 5.8 Equine Influenza
- 5.8.1 Equine Influenza Market Estimates And Forecasts, 2017 - 2030 (USD Million)
- 5.9 West Nile Virus
- 5.9.1 West Nile Virus Market Estimates And Forecasts, 2017 - 2030 (USD Million)
- 5.10 Tetanus
- 5.10.1 Tetanus Market Estimates And Forecasts, 2017 - 2030 (USD Million)
- 5.11 Others
- 5.11.1 Others Market Estimates And Forecasts, 2017 - 2030 (USD Million)
Chapter 6 Equine Healthcare Market: Segment Analysis, By Activity, 2017 - 2030 (USD Million)
- 6.1 Activity Market Share Analysis, 2021 & 2030
- 6.2 Equine Healthcare market: Activity movement analysis
- 6.3 Sports/Racing
- 6.3.1 Sports/Racing Market Estimates And Forecasts, 2017 - 2030 (USD Million)
- 6.4 Recreation
- 6.4.1 Recreation Market Estimates And Forecasts, 2017 - 2030 (USD Million)
- 6.5 Others
- 6.5.1 Others Market Estimates And Forecasts, 2017 - 2030 (USD Million)
Chapter 7 Equine Healthcare Market: Segment Analysis, By Distribution Channel, 2017 - 2030 (USD Million)
- 7.1 Distribution Channel Market Share Analysis, 2021 & 2030
- 7.2 Equine Healthcare Market: Distribution Channel Analysis Movement Analysis
- 7.3 Veterinary Hospitals & Clinics
- 7.3.1 Veterinary Hospitals & Clinics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
- 7.4 E-Commerce
- 7.4.1 E-Commerce Market Estimates And Forecasts, 2017 - 2030 (USD Million)
- 7.5 Others
- 7.5.1 Others Market Estimates And Forecasts, 2017 - 2030 (USD Million)
Chapter 8 Equine Healthcare Market: Regional Market Analysis, By Product, Indication, Activity, and Distribution Channel 2017 - 2030 (USD Million)
- 8.1 Regional Market Share Analysis, 2021 & 2030
- 8.2 Regional Market Snapshot
- 8.3 North America
- 8.3.1 North America Equine Healthcare Market Estimates And Forecasts By Countries, 2017 - 2030 (USD Million)
- 8.3.2 U.S.
- 8.3.2.1 U.S. Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
- 8.3.3 Canada
- 8.3.3.1 Canada Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
- 8.4 Europe
- 8.4.1 Europe Equine Healthcare Market Estimates and Forecasts By Countries, 2017 - 2030 (USD MILLION)
- 8.4.2 U.K.
- 8.4.2.1 U.K. Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
- 8.4.3 Germany
- 8.4.3.1 Germany Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
- 8.4.4 France
- 8.4.4.1 France Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
- 8.4.5 Italy
- 8.4.5.1 Italy Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
- 8.4.6 Spain
- 8.4.6.1 Spain Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
- 8.5.2 Japan
- 8.5.2.1 Japan Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
- 8.5.3 China
- 8.5.3.1 China Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
- 8.5.4 India
- 8.5.4.1 India Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
- 8.5.5 Australia
- 8.5.5.1 Australia Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
- 8.5.6 South Korea
- 8.5.6.1 South Korea Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
- 8.6 Latin America
- 8.6.1 Latin America Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
- 8.6.2 Brazil
- 8.6.2.1 Brazil Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
- 8.6.3 Mexico
- 8.6.3.1 Mexico Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
- 8.6.4 Argentina
- 8.6.4.1 Argentina Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
- 8.7 MEA
- 8.7.1 MEA Equine Healthcare Market Estimates And Forecasts By Countries, 2017 - 2030 (USD Million)
- 8.7.2 South Africa
- 8.7.2.1 South Africa Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
- 8.7.2 Saudi Arabia
- 8.7.2.1 Saudi Arabia Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 9Equine Healthcare Market - Competitive Landscape
- 9.1 Company Profiles
- 9.1.1 Zoetis
- 9.1.1.1 Company Overview
- 9.1.1.2 Financial Performance
- 9.1.1.3 Product/Service Benchmarking
- 9.1.1.4 Strategic Initiatives
- 9.1.2 Boehringer Ingelheim International GmbH
- 9.1.2.1 Company Overview
- 9.1.2.2 Financial Performance
- 9.1.2.3 Product/Service Benchmarking
- 9.1.2.4 Strategic Initiatives
- 9.1.3 Ceva
- 9.1.3.1 Company Overview
- 9.1.3.2 Financial Performance
- 9.1.3.3 Product/Service Benchmarking
- 9.1.3.4 Strategic Initiatives
- 9.1.4 SOUND
- 9.1.4.1 Company Overview
- 9.1.4.2 Financial Performance
- 9.1.4.3 Product/Service Benchmarking
- 9.1.4.4 Strategic Initiatives
- 9.1.5 MERCK & CO., INC.
- 9.1.5.1 Company Overview
- 9.1.5.2 Financial Performance
- 9.1.5.3 Product/Service Benchmarking
- 9.1.5.4 Strategic Initiatives
- 9.1.6 Hallmarq Veterinary Imaging
- 9.1.6.1 Company Overview
- 9.1.6.2 Financial Performance
- 9.1.6.3 Product/Service Benchmarking
- 9.1.6.4 Strategic Initiatives
- 9.1.7 ESAOTE SPA
- 9.1.7.1 Company Overview
- 9.1.7.2 Financial Performance
- 9.1.7.3 Product/Service Benchmarking
- 9.1.7.4 Strategic Initiatives
- 9.1.8 Vetoquinol S.A.
- 9.1.8.1 Company Overview
- 9.1.8.2 Financial Performance
- 9.1.8.3 Product/Service Benchmarking
- 9.1.8.4 Strategic Initiatives
- 9.1.9 IDEXX Laboratories, Inc.
- 9.1.9.1 Company Overview
- 9.1.9.2 Financial Performance
- 9.1.9.3 Product/Service Benchmarking
- 9.1.9.4 Strategic Initiatives
- 9.1.10 Dechra Pharmaceuticals PLC
- 9.1.10.1 Company Overview
- 9.1.10.2 Financial Performance
- 9.1.10.3 Product/Service Benchmarking
- 9.1.10.4 Strategic Initiatives
- 9.2 Market Participation Categorization
- 9.3 Company Market Position Analysis - Heat Map Analysis
- 9.4 Synergy Analysis: Major Deals & Strategic Alliances
- 9.5 List of Key Companies
